---
document_datetime: 2023-09-21 17:38:47
document_pages: 2
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/ifirmacombi-epar-all-authorised-presentations_en.pdf
document_name: ifirmacombi-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 2.5603617
conversion_datetime: 2025-12-25 00:40:52.158118
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| EU Number       | Name        | Strength       | Pharmaceutic al Form   | Route of Administration   | Packaging                  | Package size   |
|-----------------|-------------|----------------|------------------------|---------------------------|----------------------------|----------------|
| EU/1/11/673/001 | Ifirmacombi | 150 mg/12.5 mg | Film-coated tablet     | Oral use                  | blister (OPA/alu/PVC//alu) | 14 tablets     |
| EU/1/11/673/002 | Ifirmacombi | 150 mg/12.5 mg | Film-coated tablet     | Oral use                  | blister (OPA/alu/PVC//alu) | 28 tablets     |
| EU/1/11/673/003 | Ifirmacombi | 150 mg/12.5 mg | Film-coated tablet     | Oral use                  | blister (OPA/alu/PVC//alu) | 30 tablets     |
| EU/1/11/673/004 | Ifirmacombi | 150 mg/12.5 mg | Film-coated tablet     | Oral use                  | blister (OPA/alu/PVC//alu) | 56 tablets     |
| EU/1/11/673/005 | Ifirmacombi | 150 mg/12.5 mg | Film-coated tablet     | Oral use                  | blister (OPA/alu/PVC//alu) | 56 x 1 tablets |
| EU/1/11/673/006 | Ifirmacombi | 150 mg/12.5 mg | Film-coated tablet     | Oral use                  | blister (OPA/alu/PVC//alu) | 84 tablets     |
| EU/1/11/673/007 | Ifirmacombi | 150 mg/12.5 mg | Film-coated tablet     | Oral use                  | blister (OPA/alu/PVC//alu) | 90 tablets     |
| EU/1/11/673/008 | Ifirmacombi | 150 mg/12.5 mg | Film-coated tablet     | Oral use                  | blister (OPA/alu/PVC//alu) | 98 tablets     |
| EU/1/11/673/009 | Ifirmacombi | 300 mg/12.5 mg | Film-coated tablet     | Oral use                  | blister (OPA/alu/PVC//alu) | 14 tablets     |
| EU/1/11/673/010 | Ifirmacombi | 300 mg/12.5 mg | Film-coated tablet     | Oral use                  | blister (OPA/alu/PVC//alu) | 28 tablets     |
| EU/1/11/673/011 | Ifirmacombi | 300 mg/12.5 mg | Film-coated tablet     | Oral use                  | blister (OPA/alu/PVC//alu) | 30 tablets     |
| EU/1/11/673/012 | Ifirmacombi | 300 mg/12.5 mg | Film-coated tablet     | Oral use                  | blister (OPA/alu/PVC//alu) | 56 tablets     |
| EU/1/11/673/013 | Ifirmacombi | 300 mg/12.5 mg | Film-coated tablet     | Oral use                  | blister (OPA/alu/PVC//alu) | 56 x 1 tablets |
| EU/1/11/673/014 | Ifirmacombi | 300 mg/12.5 mg | Film-coated tablet     | Oral use                  | blister (OPA/alu/PVC//alu) | 84 tablets     |
| EU/1/11/673/015 | Ifirmacombi | 300 mg/12.5 mg | Film-coated tablet     | Oral use                  | blister (OPA/alu/PVC//alu) | 90 tablets     |
| EU/1/11/673/016 | Ifirmacombi | 300 mg/12.5 mg | Film-coated            | Oral use                  | blister (OPA/alu/PVC//alu) | 98 tablets     |

tablet

<div style=\"page-break-after: always\"></div>

| EU/1/11/673/017   | Ifirmacombi   | 300 mg/25 mg   | Film-coated tablet   | Oral use   | blister (OPA/alu/PVC//alu)   | 14 tablets     |
|-------------------|---------------|----------------|----------------------|------------|------------------------------|----------------|
| EU/1/11/673/018   | Ifirmacombi   | 300 mg/25 mg   | Film-coated tablet   | Oral use   | blister (OPA/alu/PVC//alu)   | 28 tablets     |
| EU/1/11/673/019   | Ifirmacombi   | 300 mg/25 mg   | Film-coated tablet   | Oral use   | blister (OPA/alu/PVC//alu)   | 30 tablets     |
| EU/1/11/673/020   | Ifirmacombi   | 300 mg/25 mg   | Film-coated tablet   | Oral use   | blister (OPA/alu/PVC//alu)   | 56 tablets     |
| EU/1/11/673/021   | Ifirmacombi   | 300 mg/25 mg   | Film-coated tablet   | Oral use   | blister (OPA/alu/PVC//alu)   | 56 x 1 tablets |
| EU/1/11/673/022   | Ifirmacombi   | 300 mg/25 mg   | Film-coated tablet   | Oral use   | blister (OPA/alu/PVC//alu)   | 84 tablets     |
| EU/1/11/673/023   | Ifirmacombi   | 300 mg/25 mg   | Film-coated tablet   | Oral use   | blister (OPA/alu/PVC//alu)   | 90 tablets     |
| EU/1/11/673/024   | Ifirmacombi   | 300 mg/25 mg   | Film-coated tablet   | Oral use   | blister (OPA/alu/PVC//alu)   | 98 tablets     |